Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients

J Int Med Res. 2003 Sep-Oct;31(5):362-9. doi: 10.1177/147323000303100502.

Abstract

We aimed to determine if successful or failed eradication of Helicobacter pylori with triple therapy causes any difference in gastric mucosal histology. Japanese H. pylori-positive patients with a healed peptic ulcer received high (n = 112) or low (n = 113) doses of triple therapy (omeprazole, amoxicillin and clarithromycin) for 1 week. Biopsies from the greater curvature of the central antrum and upper corpus were taken 6 weeks and 30 weeks after treatment completion, and gastric mucosal histology compared between successful (n = 171) and failed (n = 34) eradication groups. Morphological variables of gastritis were graded according to the updated Sydney System. Successful eradication therapy was defined as improvement in inflammation, neutrophil activity and atrophy; failed eradication therapy as improvement in inflammation and neutrophil activity only. Gastric mucosal atrophy gradually improved (in addition to improvements in inflammation and neutrophil activity) with successful eradication of H. pylori infection.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Amoxicillin / administration & dosage
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Ulcer Agents / administration & dosage
  • Biopsy
  • Clarithromycin / administration & dosage
  • Drug Therapy, Combination*
  • Female
  • Gastric Mucosa / microbiology
  • Helicobacter pylori / metabolism*
  • Humans
  • Inflammation
  • Japan
  • Male
  • Middle Aged
  • Omeprazole / administration & dosage
  • Peptic Ulcer / microbiology*
  • Peptic Ulcer / therapy*
  • Time Factors

Substances

  • Anti-Bacterial Agents
  • Anti-Ulcer Agents
  • Amoxicillin
  • Clarithromycin
  • Omeprazole